FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Professur für Molekulare Mechanismen der Organfibrose
Reallocation / Closing: 30.09.2022
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Department of Medicine 3 – Rheumatology and Immunology
Lehrstuhl für Innere Medizin III
Overview
Publications
(354)
Research Grants
(2)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual (2019)
Fasano S, Riccardi A, Messiniti V, Caramaschi P, Rosato E, Maurer B, Smith V, et al.
Journal article
Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases (2019)
Fischer A, Distler J
Journal article, Review article
Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc (2019)
Liang R, Kagwiria R, Zehender A, Dees C, Bergmann C, Krasowska D, Michalska-Jakubus M, et al.
Journal article
Predictors for the Development of Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) - Data from the German SSc-Network (2019)
Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al.
Conference contribution
Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis–associated interstitial lung disease (2019)
Wollin L, Distler J, Denton CP, Gahlemann M
Journal article, Review article
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study (2019)
Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ, Truchetet ME, et al.
Journal article
Response to: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: Contribution of antisynthetase antibodies to improve current classification criteria' by Greco et al (2019)
Knitza J, Cavagna L, Schett G, Distler J
Journal article
PU.1 controls fibroblast polarization and tissue fibrosis (2019)
Wohlfahrt T, Rauber S, Uebe S, Luber M, Soare A, Ekici AB, Weber S, et al.
Journal article
The non-neuronal cyclin-dependent kinase 5 is a fibrotic mediator potentially implicated in systemic sclerosis and a novel therapeutic target (2018)
Wei J, Marangoni RG, Fang F, Wang W, Huang J, Distler J, Varga J
Journal article
Targeting TGF-beta signaling for the treatment of fibrosis (2018)
Györfi AH, Matei AE, Distler J
Journal article
‹
1
...
16
17
18
19
20
...
35
›